News tagged with heat shock proteins


Ganetespib shows potency against ALK-positive lung cancer and overcomes crizotinib resistance

A drug that indirectly impairs the function of several cancer-driving proteins, including anaplastic lymphoma kinase (ALK), may be an effective new treatment for patients with ALK—positive non-small cell lung cancer.

Cancer created Mar 26, 2013 | popularity not rated yet | comments 0

Modified protein could become first effective treatment for vitiligo

Loyola University Chicago Stritch School of Medicine researchers have developed a genetically modified protein that dramatically reverses the skin disorder vitiligo in mice, and has similar effects on immune ...

Medical research created Feb 27, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast

Progressive exercise training may benefit diabetic neuropathy

(HealthDay)—In a rat model of diabetes, exercise is associated with decreased diabetes-associated neuropathic pain, which correlates with increased expression of heat shock protein 72 (Hsp72), according to a study published ...

Medical research created Feb 12, 2013 | popularity not rated yet | comments 0 | with audio podcast

New findings on heat shock proteins may shed light on variety of debilitating diseases

UCLA researchers, in a finding that runs counter to conventional wisdom, have discovered for the first time that a gene thought to express a protein in all cells that come under stress is instead expressed only in specific ...

Medical research created Jan 29, 2013 | popularity not rated yet | comments 0 | with audio podcast

Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo

Researchers have demonstrated that combination therapy with PU-H71 and ruxolitinib increases the durability and effectiveness of a treatment that had previously shown limited utility for patients with myelofibrosis.

Cancer created Dec 09, 2012 | popularity not rated yet | comments 0

Protein tug of war points toward better therapies for cardiovascular disease

Two proteins are in a tug of war that determines how much the body makes of superoxide, a highly reactive and potentially destructive product of oxygen that's dramatically elevated in cardiovascular disease, ...

Cardiology created Nov 15, 2012 | popularity 5 / 5 (2) | comments 0 | with audio podcast

New drug to target and destroy tumor cells developed

A new drug created at the University of Minnesota may hold the answer to defeating pancreatic cancer, according to results published today in the prestigious journal Science Translational Medicine.

Cancer created Oct 18, 2012 | popularity 5 / 5 (4) | comments 0 | with audio podcast

Impaired protein degradation causes muscle diseases

New insights into certain muscle diseases, the filaminopathies, are reported by an international research team led by Dr. Rudolf Andre Kley of the RUB's University Hospital Bergmannsheil in the journal Brain. The scientists from t ...

Medical research created Sep 25, 2012 | popularity not rated yet | comments 0

Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy

Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal stresses and environmental challenges since life began. As an integral part ...

Cancer created May 22, 2012 | popularity not rated yet | comments 0

Treatment hope for Duchenne muscular dystrophy

An international team led by the University of Melbourne Australia, has found that increasing a specific protein in muscles could help treat Duchenne muscular dystrophy (DMD), a severe and progressive muscle wasting disease ...

Diseases, Conditions, Syndromes created Apr 04, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers find potential solution to melanoma's resistance to vemurafenib

Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.

Cancer created Feb 28, 2012 | popularity not rated yet | comments 0 | with audio podcast

Researchers indentify a cell-permeable peptide that inhibits hepatitis C

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.

Diseases, Conditions, Syndromes created Jan 31, 2012 | popularity not rated yet | comments 0 | with audio podcast

How protein networks stabilize muscle fibers: Same mechanism as for DNA

The same mechanism that stabilises the DNA in the cell nucleus is also important for the structure and function of vertebrate muscle cells. This has been established by RUB-researchers led by Prof. Dr. Wolfgang Linke (Institute ...

Genetics created Jan 23, 2012 | popularity not rated yet | comments 0

Pill some day may prevent serious foodborne illness, scientist says

Modified probiotics, the beneficial bacteria touted for their role in digestive health, could one day decrease the risk of Listeria infection in people with susceptible immune systems, according to Purdue University resear ...

Diseases, Conditions, Syndromes created Jan 09, 2012 | popularity not rated yet | comments 0 | with audio podcast

Towards more effective treatment for multiple myeloma

A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, ...

Cancer created Jan 09, 2012 | popularity 5 / 5 (2) | comments 0 | with audio podcast